Clinical seizures following acute ischemic stroke (AIS) appear to contribute to worse neurologic outcomes. However, the effect of electrographic epileptiform abnormalities (EAs) more broadly is less clear. Here, we evaluate the impact of EAs, including electrographic seizures and periodic and rhythmic patterns, on outcomes in patients with AIS.
This is a retrospective study of all patients with AIS aged ≥ 18 years who underwent at least 18 h of continuous electroencephalogram (EEG) monitoring at a single center between 2012 and 2017. EAs were classified according to American Clinical Neurophysiology Society (ACNS) nomenclature and included seizures and periodic and rhythmic patterns. EA burden for each 24-h epoch was defined using the following cutoffs: EA presence, maximum daily burden < 10% versus > 10%, maximum daily burden < 50% versus > 50%, and maximum daily burden using categories from ACNS nomenclature (“rare” < 1%; “occasional” 1–9%; “frequent” 10–49%; “abundant” 50–89%; “continuous” > 90%). Maximum EA frequency for each epoch was dichotomized into ≥ 1.5 Hz versus < 1.5 Hz. Poor neurologic outcome was defined as a modified Rankin Scale score of 4–6 (vs. 0–3 as good outcome) at hospital discharge.
One hundred and forty-three patients met study inclusion criteria. Sixty-seven patients (46.9%) had EAs. One hundred and twenty-four patients (86.7%) had poor outcome. On univariate analysis, the presence of EAs (OR 3.87 [1.27–11.71], p = 0.024) and maximum daily burden > 10% (OR 12.34 [2.34–210], p = 0.001) and > 50% (OR 8.26 [1.34–122], p = 0.035) were associated with worse outcomes. On multivariate analysis, after adjusting for clinical covariates (age, gender, NIHSS, APACHE II, stroke location, stroke treatment, hemorrhagic transformation, Charlson comorbidity index, history of epilepsy), EA presence (OR 5.78 [1.36–24.56], p = 0.017), maximum daily burden > 10% (OR 23.69 [2.43–230.7], p = 0.006), and maximum daily burden > 50% (OR 9.34 [1.01–86.72], p = 0.049) were associated with worse outcomes. After adjusting for covariates, we also found a dose-dependent association between increasing EA burden and increasing probability of poor outcomes (OR 1.89 [1.18–3.03] p = 0.009). We did not find an independent association between EA frequency and outcomes (OR: 4.43 [.98–20.03] p = 0.053). However, the combined effect of increasing EA burden and frequency ≥ 1.5 Hz (EA burden * frequency) was significantly associated with worse outcomes (OR 1.64 [1.03–2.63] p = 0.039).
Electrographic seizures and periodic and rhythmic patterns in patients with AIS are associated with worse outcomes in a dose-dependent manner. Future studies are needed to assess whether treatment of this EEG activity can improve outcomes.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Friedman D, Claassen J, Hirsch LJ. Continuous electroencephalogram monitoring in the intensive care unit. Anesth Analg. 2009;109:506–23.
Alberti A, Paciaroni M, Caso V, Venti M, Palmerini F, Agnelli G. Early seizures in patients with acute stroke: frequency, predictive factors, and effect on clinical outcome. Vasc Heal Risk Manag. 2008;4:715–20.
Huang CW, Saposnik G, Fang J, Steven DABJ. Seizures worsen stroke outcome: new evidence from a large sample. Epilepsy Curr. 2014;15:30–1.
Lesser RP, Luders H, Dinner DSMH. Epileptic seizures due to thrombotic and embolic cerebrovascular disease in older patients. Epilepsia. 1985;26:622–30.
Hornig CR, Buttner T, Hufnagel A, Schrider-Rosenstock KDW. Epileptic seizures following ischemic cerebral infarction: clinical picture, CT findings, and prognosis. EurArchPsychiatry NeurolSci. 1990;239:379–83.
Burneo JG, Fang J, Saposnik G. Impact of seizures on morbidity and mortality after stroke: a Canadian multi-centre cohort study. Eur J Neurol. 2010;17:52–8.
Claassen J, Mayer SA, Kowalski RG, Emerson RG, Hirsch LJ. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology. 2004;62:1743–8.
Belcastro V, Vidale S, Gorgone G, Pisani LR, Sironi L, Arnaboldi M, et al. Non-convulsive status epilepticus after ischemic stroke: a hospital-based stroke cohort study. J Neurol. 2014;261:2136–42.
Claassen J, Jetté N, Chum F, Green R, Schmidt M, Choi H, et al. Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology. 2007;69:1356–65.
De Marchis GM, Pugin D, Meyers E, Velasquez A, Suwatcharangkoon S, Park S, et al. Seizure burden in subarachnoid hemorrhage associated with functional and cognitive outcome. Neurology. 2016;86:253–60.
Zafar SF, Postma EN, Biswal S, Boyle EJ, Bechek S, O’Connor K, et al. Effect of epileptiform abnormality burden on neurologic outcome and antiepileptic drug management after subarachnoid hemorrhage. Clin Neurophysiol. 2018;129:2219–27.
Payne ET, Zhao XY, Frndova H, McBain K, Sharma R, Hutchison JS, et al. Seizure burden is independently associated with short term outcome in critically ill children. Brain. 2014;137:1429–38.
Witsch J, Frey HP, Schmidt JM, Velazquez A, Falo CM, Reznik M, et al. Electroencephalographic periodic discharges and frequency-dependent brain tissue hypoxia in acute brain injury. JAMA Neurol. 2017;74:301–9.
Vespa PM, Miller C, McArthur D, Eliseo M, Etchepare M, Hirt D, et al. Nonconvulsive electrographic seizures after traumatic brain injury result in a delayed, prolonged increase in intracranial pressure and metabolic crisis. Crit Care Med. 2007;35:2830–6.
Struck AF, Westover MB, Hall LT, Deck GM, Cole AJ, Rosenthal ES. Metabolic correlates of the ictal-interictal continuum: FDG-PET during continuous EEG. Neurocrit Care. 2016;24:324–31.
Westover MB, Shafi MM, Bianchi MT, Moura LM, O’Rourke D, Rosenthal ES, et al. The probability of seizures during EEG monitoring in critically ill adults. Clinical Neurophysiology. 2015;126:463–71.
Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke. 1993;24:35–41.
Hirsch LJ, Laroche SM, Gaspard N, Gerard E, Svoronos A, Herman ST, et al. American clinical neurophysiology society’s standardized critical care EEG terminology: 2012 version. J Clin Neurophysiol. 2013;30:1–27.
Ruiz AR, Vlachy J, Lee JW, Gilmore EJ, Ayer T, Haider HA, et al. Association of periodic and rhythmic electroencephalographic patterns with seizures in critically ill patients. JAMA Neurol. 2017;74:181–8.
Kim JA, Rosenthal ES, Biswal S, Zafar S, Shenoy AV, O’Connor KL, et al. Epileptiform abnormalities predict delayed cerebral ischemia in subarachnoid hemorrhage. Clin Neurophysiol. 2017;128:1091–9.
Farrell B, Godwin J, Richards S, Warlow C. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry. 1991;54:1044–54.
Rost NS, Bottle A, Lee JM, Randall M, Middleton S, Shaw L, et al. Stroke severity is a crucial predictor of outcome: an international prospective validation study. J Am Heart Assoc. 2016;5:e002433.
Ernst M, Boers AM, Forkert ND, Berkhemer OA, Roos YB, Dippel DW, et al. Impact of ischemic lesion location on the mRS score in patients with ischemic stroke: a voxel-based approach. Am J Neuroradiol. 2018;39:1989–94.
Sommer P, Posekany A, Serles W, Marko M, Scharer S, Fertl E, et al. Is functional outcome different in posterior and anterior circulation stroke? Stroke. 2018 Nov;49(11):2728–32.
van Kranendonk KR, Treurniet KM, Boers AMM, Berkhemer OA, van den Berg LA, Chalos V, et al. Hemorrhagic transformation is associated with poor functional outcome in patients with acute ischemic stroke due to a large vessel occlusion. J Neurointerv Surg. 2019;11:464–8.
Moon BH, Park SK, Jang DK, Jang KS, Kim JT, Han YM. Use of APACHE II and SAPS II to predict mortality for hemorrhagic and ischemic stroke patients. J Clin Neurosci. 2015;22:111–5.
Mecarelli O, Pro S, Randi F, Dispenza S, Correnti A, Pulitano P, et al. EEG patterns and epileptic seizures in acute phase stroke. Cerebrovasc Dis. 2011;31:191–8.
Vespa PM, O’Phelan K, Shah M, Mirabelli J, Starkman S, Kidwell C, et al. Acute seizures after intracerebral hemorrhage: A factor in progressive midline shift and outcome. Neurology. 2003;60:1441–6.
Reith J, Jørgensen HS, Nakayama H, Raaschou HO, Olsen TS. Seizures in acute stroke: predictors and prognostic significance: The copenhagen stroke study. Stroke. 1997;28:1585–9.
Bladin CF, Alexandrov AV, Bellavance A, Bornstein N, Chambers B, Coté R, et al. Background: seizures after stroke, a prospective multicenter study. Arch Neurol. 2000;57:1617–22.
Myint PK, Staufenberg EF, Sabanathan K. Post-stroke seizure and post-stroke epilepsy. Postgrad Med J. 2006;82:568–72.
Sivaraju A, Gilmore EJ. Understanding and managing the ictal-interictal continuum in neurocritical care. Curr Treat Options Neurol. 2016;18:8.
Alvarez V, Ruiz AA, LaRoche S, Hirsch LJ, Parres C, Voinescu PE, et al. The use and yield of continuous EEG in critically ill patients: A comparative study of three centers. Clin Neurophysiol. 2017;128:570–8.
Brodie MJ, Richens AYA. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK lamotrigine/carbamazepine monotherapy trail group. Lancet. 1995;345:476–9.
Perucca P, Carter J, Vahle VGF. Adverse antiepileptic drug effects Toward a clinically and neurophysiologically relevant taxonomy. Neurology. 2009;72:1223–9.
Baker GA, Jacoby A, Buck D, Stalgis CMD. Quality of life of people with epilepsy: a European study. Epilepsia. 1997;38:353.
Naidech AM, Kreiter KT, Janjua N, Ostapkovich N, Parra A, Commichau C, et al. Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke. 2005;36:583–7.
Yoon SJ, Joo YJ, Kim YB, Hong CKCJ. Effects of prophylactic antiepileptic drugs on clinical outcomes in patients with a good clinical grade suffering from aneurysmal subarachnoid hemorrhage. J cerbrovascular Endovasc neurosurgery. 2015;17:166–72.
Gaspard N, Hirsch LJ, LaRoche SM, Hahn CD, Westover MB. Interrater agreement for critical care EEG terminology. Epilepsia. 2014;55:1366–73.
Claassen J, Taccone FS, Horn P, Holtkamp M, Stocchetti N, Oddo M. Recommendations on the use of EEG monitoring in critically ill patients: consensus statement from the neurointensive care section of the ESICM. Intensive Care Med. 2013;39:1337–511.
This work was supported by NIH-NINDSK23NS114201 (SFZ) and research support from SAGE therapeutics (SFZ, MBW, ESR).
Conflict of interest
Dr. Tabaeizadeh, Dr. Aboul Nour, Dr. Shoukat, Dr. Sun, Dr. Javed, Dr. Kassa, Dr. Edhi, Dr. Bordbar, J. Gallagher, V Moura, M. Ghanta, YP Shao, Dr. Jin, Dr. Cole, Dr. Rosenthal reports grants from Sage Therapeutics, during the conduct of the study, Dr. Westover reports grants from Sage Therapeutics, grants from NIH-NINDS 1K23NS090900, grants from NIH-NINDS1R01NS102190, during the conduct of the study; Dr. Zafar reports grants from Sage Therapeutics, grants from NIH-NINDS 1K23NS114201 during the conduct of the study.
Ethical approval/Informed consent
This manuscript adheres to ethical guidelines. The study was conducted under a protocol approved by the institutional review board. Informed consent was not required for this retrospective study.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Tabaeizadeh, M., Aboul Nour, H., Shoukat, M. et al. Burden of Epileptiform Activity Predicts Discharge Neurologic Outcomes in Severe Acute Ischemic Stroke. Neurocrit Care 32, 697–706 (2020). https://doi.org/10.1007/s12028-020-00944-0
- Ischemic stroke
- Epileptiform abnormalities
- Continuous electroencephalogram